Case 1 was a 43-year-old 
Introduction

Primary biliary cirrhosis (PBC) is characterized by abnormalities in both cellular and humoral immunity. It is associ-
Laboratory data showed elevated levels of LDH (515 IU/L; normal, 275-475 IU/L). Surface makers of B-cell lymphocyte were positive (CD10 and CD19). The result of chromosomal analysis was t (9 ; 22). She was diagnosed as having acute lymphoid leukemia (ALL) by bone marrow examination. Chemotherapy by combination of adriamycin (ADM) + vincristine (VCR) + cyclophosphamide (CPM) + predonisolone (PSL) was planned, but her family did not approve. VCR+PSL therapy was performed and she died after 6 months. Case 2. A 54-year-old woman was referred to our department in 1997 because of liver dysfunction and esophageal varices. She had suffered from Raynaud's phenomenon for 2
F i g u r e 1 . We s t e r n b l o t a n a l y s i s u s i n g P DC-E 2 p r o t e i n s p ur i f i e d f r o m b o v i n e h e a r t i n s e r u m o f c a s e 1 .
F i g u r e 2 . L i v e r b i o p s y s p e c i me n s h o ws l y mp h o c y t e s i n f i l t r a t i o n i n s l i g h t l y e n l a r g e d p o r t a l t r a c t s wi t h b i l e d u c t s d a ma g e . He ma t o x y l i n a n d e o s i n s t a i n i n g , o r i g i n a l ma g n i f i c a t i o n
6-6.0 IU/L), and FDP (74.2 μg/mL; normal, 0-5 μg/mL). Surface makers of leukemic cells were positive (CD13 and CD33). The result of chromosomal analysis was t (15 ; 17). She was diagnosed as having acute promyelocytic leukemia (APL) by bone marrow examination. Chemotherapy by all-trans retinoic acid (ATRA) + cydarabine (AraC) + idarubicin hydrochloride (IDR) has been continued for APL, and her symptoms are at present, stable.
Discussion
Malignant blood dyscrasia complicating PBC, in particular the lymphoproliferative neoplasm, has been reported (1, 2). However, the incidence of this disease is not specifically high in patients with PBC. The pathogenesis of lymphoma or multiple myeloma complicating PBC has been suggested with autoimmune mechanisms (3). It is difficult to explain the pathogenesis of the association with ALL or APL and
PBC by an autoimmune mechanism. Autoantibodies against Sp100 and promyelocytic leukemia protein (PML), which are aberrantly expressed in promyelocytic leukemia cells (4) , are found simultaneously in 90% of the patients with PBC. The Sp100 and PML are present in the so-called nuclear dots and against the autoantibodies which are present in a subpopulation of PBC patients (5) . However, these antibodies were negative in case 2.
Recent reports have indicated that patients with PBC may have a higher incidence of hepatobiliary malignancies (6, 7) . Some data suggest that there is an increased risk of breast cancer in PBC (8) (9) (10) (11) (12) , however the overall frequency of hematologic malignancy in patients with scleroderma is in fact lower than the nationwide frequency (12) 
